FDA official logo
GSRS logoPFDA official logo

RALUDOTATUG DERUXTECAN

UNII:BPQ010OFD7
Formula:
Preferred Substance Name:RALUDOTATUG DERUXTECAN

  • 2610074-57-0
  • DS6000A
  • DS-6000A
  • GAMMA1 HEAVY CHAIN HUMANIZED (1-452) (VH (HOMO SAPIENS IGHV1-3*01 (86.7%)-(IGHD)-IGHJ4*01(93.3%), CDR-IMGT (8.8.15) (26-33.51-58.97-111))(1-122) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 (CH1 R120 (219)(123-220), HINGE 1-15 (221-235), CH2 (236-345), CH3 E12 (361), M14 (363) (346-450), CHS (451-452)) (123-452)), (225-213')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-213') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (86%) -IGKJ1*01 (91.7%), CDR-IMGT(6.3.8) (27-32.50-52.89-96)) (1'-106')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152), V101(190) (107'-213')); DIMER (231-231'': 234-234'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA; CONJUGATED, ON AN AVERAGE OF 8 CYSTEINYL, TO DERUXTECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN G CADHERIN 6) (HUMAN-RATTUS NORVEGICUS MONOCLONAL MABU-9014A .GAMMA.1-CHAIN), COMPLEX WITH HUMAN-RATTUS NORVEGICUS MONOCLONAL MABU-9014A .KAPPA.-CHAIN, DIMER, OCTAKIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)GLYCYLGLYCYL-L-PHENYLALANYL-N-((2-(((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)-2-OXOETHOXY)METHYL)GLYCINAMIDE
  • IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CDH6(CADHERIN 6, K-CADHERIN (FOETAL KIDNEY), CADHERIN 6 TYPE 2)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO DERUXTECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE
  • RALUDOTATUG DERUXETCAN [USAN]
  • RALUDOTATUG DERUXTECAN [INN]
  • RALUDOTATUG DERUXTECAN [WHO-DD]




UNII - BPQ010OFD7 | UNII Search Service